|
DE69829469D1
(de)
*
|
1997-01-24 |
2005-04-28 |
Avi Biopharm Inc |
Verfahren und konjugat zur behandlung von helicobacter pylori-infektionen
|
|
US6455495B1
(en)
*
|
1997-02-14 |
2002-09-24 |
The Salk Institute For Biological Studies |
Methods and compositions for delivery of therapeutic agents to bone tissue employing conjugates of negatively charged peptide oligomers with therapeutic agents
|
|
ES2210761T3
(es)
|
1997-05-21 |
2004-07-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Composicion y procedimiento para mejorar el transporte a traves de las membranas biologicas.
|
|
US6958148B1
(en)
|
1998-01-20 |
2005-10-25 |
Pericor Science, Inc. |
Linkage of agents to body tissue using microparticles and transglutaminase
|
|
US6919076B1
(en)
|
1998-01-20 |
2005-07-19 |
Pericor Science, Inc. |
Conjugates of agents and transglutaminase substrate linking molecules
|
|
US20020064520A1
(en)
*
|
1999-08-19 |
2002-05-30 |
Yanina Rozenberg |
Targeted artificial gene delivery
|
|
AU769315B2
(en)
|
1999-08-24 |
2004-01-22 |
Cellgate, Inc. |
Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
|
|
US7229961B2
(en)
|
1999-08-24 |
2007-06-12 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into ocular tissues
|
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
|
US6669951B2
(en)
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
|
EP3020804A1
(en)
|
2000-07-06 |
2016-05-18 |
Sarepta Therapeutics, Inc. |
Transforming growth factor beta (tgf- ) blocking agent-treated stem cell composition and method
|
|
AU8466501A
(en)
|
2000-07-21 |
2002-02-05 |
Essentia Biosystems Inc |
Multi-component biological transport systems
|
|
JP2004523480A
(ja)
*
|
2000-08-22 |
2004-08-05 |
ニュー リバー ファーマシューティカルズ， インコーポレイテッド |
活性作用物質送達系ならびに活性作用物質の保護および投与方法
|
|
JP2006516948A
(ja)
*
|
2000-11-14 |
2006-07-13 |
ニュー リバー ファーマシューティカルズ インコーポレイテッド |
硫酸アバカビルを含有する新規な薬剤化合物および同化合物の製造ならびに使用方法
|
|
AU2003217676B2
(en)
*
|
2002-02-22 |
2009-06-11 |
Takeda Pharmaceutical Company Limited |
Active agent delivery systems and methods for protecting and administering active agents
|
|
EP2260874A1
(en)
|
2003-01-06 |
2010-12-15 |
Angiochem Inc. |
Aprotinin analogs as carriers across the blood-brain barrier
|
|
US20050234002A1
(en)
|
2004-01-23 |
2005-10-20 |
Mourich Dan V |
Antisense oligomers and methods for inducing immune tolerance and immunosuppression
|
|
US8974774B2
(en)
|
2004-03-03 |
2015-03-10 |
Revance Therapeutics, Inc. |
Compositions and methods for topical diagnostic and therapeutic transport
|
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
PT1766012E
(pt)
|
2004-07-02 |
2011-09-05 |
Avi Biopharma Inc |
Método e composto antisense antibacteriano
|
|
CA2596506C
(en)
|
2005-02-09 |
2021-04-06 |
Avi Biopharma, Inc. |
Antisense composition and method for treating muscle atrophy
|
|
CA2597958C
(en)
|
2005-02-18 |
2019-01-15 |
Angiochem Inc. |
Molecules for transporting a compound across the blood-brain barrier
|
|
MX2007010673A
(es)
|
2005-03-03 |
2008-04-07 |
Revance Therapeutics Inc |
Composiciones y metodos para la aplicacion topica y el suministro transdermico de toxinas botulinicas.
|
|
AU2006218455A1
(en)
|
2005-03-03 |
2006-09-08 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of an oligopeptide
|
|
US8067571B2
(en)
|
2005-07-13 |
2011-11-29 |
Avi Biopharma, Inc. |
Antibacterial antisense oligonucleotide and method
|
|
EP1915161B1
(en)
|
2005-07-13 |
2017-04-26 |
Sarepta Therapeutics, Inc. |
Antisense antibacterial method and compound
|
|
JP5436856B2
(ja)
|
2005-07-15 |
2014-03-05 |
アンジオケム インコーポレーティッド |
薬学的複合体における担体としてのアプロチニンポリペプチドの使用
|
|
US8501704B2
(en)
|
2005-11-08 |
2013-08-06 |
Sarepta Therapeutics, Inc. |
Immunosuppression compound and treatment method
|
|
EP1935434A1
(en)
*
|
2006-12-19 |
2008-06-25 |
Novosom AG |
Construction and use of transfection enhancer elements
|
|
US9365634B2
(en)
|
2007-05-29 |
2016-06-14 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
|
ES2665017T3
(es)
|
2008-03-20 |
2018-04-24 |
University Of Florida Research Foundation, Inc. |
Mejorar el potencial de retorno y reparación de células madre en lesiones vasculares
|
|
EP2143726A1
(en)
*
|
2008-07-11 |
2010-01-13 |
Novosom AG |
Nucleic acid comprising zwitterionic nucleotides
|
|
CN102245642A
(zh)
|
2008-10-15 |
2011-11-16 |
安吉奥开米公司 |
Glp-1激动剂的结合物及其用途
|
|
WO2010063122A1
(en)
|
2008-12-05 |
2010-06-10 |
Angiochem Inc. |
Conjugates of neurotensin or neurotensin analogs and uses thereof
|
|
EP2376633A1
(en)
*
|
2008-12-17 |
2011-10-19 |
AVI BioPharma, Inc. |
Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
|
|
CN102510759A
(zh)
|
2009-04-20 |
2012-06-20 |
安吉奥开米公司 |
利用与血管肽-2类似物结合的抗癌剂治疗卵巢癌
|
|
JP5797191B2
(ja)
|
2009-06-05 |
2015-10-21 |
１３セラピューティクス， インコーポレイテッド |
免疫調節ペプチドおよびその使用
|
|
JP5932642B2
(ja)
|
2009-07-02 |
2016-06-08 |
アンジオケム インコーポレーテッド |
多量体ペプチドコンジュゲートおよびその使用
|
|
WO2011150408A2
(en)
|
2010-05-28 |
2011-12-01 |
Avi Biopharma, Inc. |
Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
|
|
US10017763B2
(en)
|
2010-09-03 |
2018-07-10 |
Sarepta Therapeutics, Inc. |
dsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups
|
|
WO2012138879A2
(en)
|
2011-04-06 |
2012-10-11 |
13Therapeutics, Inc. |
Peptides for the treatment of hearing
|
|
US20130085139A1
(en)
|
2011-10-04 |
2013-04-04 |
Royal Holloway And Bedford New College |
Oligomers
|
|
CN108864192A
(zh)
|
2011-11-18 |
2018-11-23 |
萨勒普塔医疗公司 |
功能改性的寡核苷酸及其亚单元
|
|
CA2868174A1
(en)
|
2012-03-20 |
2013-09-26 |
Sarepta Therapeutics, Inc. |
Boronic acid conjugates of oligonucleotide analogues
|
|
GB201210358D0
(en)
*
|
2012-06-12 |
2012-07-25 |
Polytherics Ltd |
Complexes
|
|
AU2013302270A1
(en)
|
2012-08-14 |
2015-03-26 |
Angiochem Inc. |
Peptide-dendrimer conjugates and uses thereof
|
|
MA41795A
(fr)
|
2015-03-18 |
2018-01-23 |
Sarepta Therapeutics Inc |
Exclusion d'un exon induite par des composés antisens dans la myostatine
|
|
EP3302489A4
(en)
|
2015-06-04 |
2019-02-06 |
Sarepta Therapeutics, Inc. |
METHOD AND COMPOUNDS FOR THE TREATMENT OF DISEASES AND SUFFERING IN CONNECTION WITH LYMPHOCYTES
|
|
JP6823055B2
(ja)
|
2015-06-15 |
2021-01-27 |
アンジオケム インコーポレーテッド |
軟髄膜癌腫症の治療方法
|
|
US20170100407A1
(en)
*
|
2015-10-07 |
2017-04-13 |
Cormedix Inc. |
Skin-penetrating formulation of taurolidine
|